Takeda Pharmaceutical Company Limited (TAK) Reports Q3 EPS of JPY279.00

Takeda Pharmaceutical Company Limited (NYSE: TAK) reported Q3 EPS of JPY279.00. Revenue for the quarter came in at JPY2219.5 billion.

For earnings history and earnings-related data on Takeda Pharmaceutical Company Limited (TAK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)